Related Experiment Video
Updated: Jul 15, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
An outcome measure in schizophrenia: mortality
1The Centre for Addiction and Mental Health, University of Toronto, Ontario. mary.seeman@utoronto.ca
Summary
Mortality rates for individuals with schizophrenia are increasing due to poor health, lifestyle, and treatments. Healthcare professionals must address this rising mortality in schizophrenia to improve patient outcomes.
Area of Science:
- Psychiatry
- Public Health
- Epidemiology
Background:
- Schizophrenia is a severe mental disorder with significant public health implications.
- Previous studies indicate elevated mortality rates in schizophrenia patients.
- The current trajectory of schizophrenia outcomes requires updated assessment.
Purpose of the Study:
- To assess the contemporary mortality rate in individuals diagnosed with schizophrenia.
- To identify factors contributing to the current outcome of schizophrenia.
Main Methods:
- Review of recent health statistics.
- Analysis of suicide and violence victim data.
- Examination of mortality statistics in schizophrenia patients.
Main Results:
- General health of individuals with schizophrenia is compromised.
- Factors include neglect, unhealthy lifestyle choices, and iatrogenic effects of treatments.
- These factors contribute to increased death rates.
Conclusions:
- There is a discernible increase in mortality among schizophrenia patients.
- Physicians and healthcare planners must implement interventions.
- Urgent action is needed to mitigate rising mortality in schizophrenia.
Related Concept Videos
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.